For Evolution Health Group, 2022 proved something of a challenging year. After years of consistent growth, revenue nudged downward by 3%, to $32.6 million from $33.6 million in 2021. The company ...

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At Health Evolution, we are committed to driving ...

BATON ROUGE, La., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, announced today that it has ...

Evolution Health Group might have fallen short on meeting 2023’s revenue growth target of 30%, but a nearly 20% increase amid a chaotic economic environment is certainly not the worst consolation ...